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Aim. Despite the beneﬁcial eﬀects of dietary restriction (DR) on lifespan, age-related diseases, including diabetes and
cardiovasculardiseases,itseﬀectsontype2diabeticnephropathyremainunknown.Thisstudyexaminedtherenoprotectiveeﬀects
of DR in Wistar fatty (fa/fa) rats (WFRs). Methods. WFRs were treated with DR (40% restriction) for 24 weeks. Urinary albumin
excretion, creatinine clearance, renal histologies, acetylated-NF-κB (p65), Sirt1 protein expression, and p62/Sqstm 1 accumulation
in the renal cortex, as well as electron microscopic observation of mitochondrial morphology and autophagosomes in proximal
tubular cells were estimated. Results. DR ameliorated renal abnormalities including inﬂammation in WFRs. The decrease in Sirt1
levels, increase in acetylated-NF-κB, and impaired autophagy in WFRs were improved by DR. Conclusions.D Re x e r t e da n t i -
inﬂammatory eﬀects and improved the dysregulation of autophagy through the restoration of Sirt1 in the kidneys of WFRs, which
resulted in the amelioration of renal injuries in type 2 diabetes.
1.Introduction
According to the International Diabetes Federation (IDF)
atlas in 2009, the estimated diabetes prevalence for 2010
has risen to 285 million, representing 6.6% of the world’s
adult population, with a prediction that by 2030 the number
of people with diabetes will have risen to 438 million [1].
Diabetes results in vascular changes and dysfunction, and
diabetic complications are the major cause of morbidity and
mortality in diabetic patients. Among diabetic vascular com-
plications, nephropathy is a leading cause of end-stage renal
disease and an independent risk factor for cardiovascular
diseases. Renal inﬂammation is recognized as one of the
important pathophysiological mechanisms and therapeutic
targets for the prevention of diabetic nephropathy and
atherosclerosis [2].
Dietary restriction (DR) has a variety of eﬀects on
lifespan extension and the delayed onset of age-related
diseases, including cardiovascular diseases and diabetes, and
is accepted as the only established antiaging experimental
paradigm [3, 4]. The beneﬁcial eﬀects of DR involve the
function of the NAD+-dependent deacetylase, Sirt1, the
expression of which is induced by DR. Sirt1 has cytoprotec-
tive eﬀects, including anti-inﬂammatory eﬀects [5–7].
In addition, autophagy is a major intracellular process
in which lysises in sthe damaged cytoplasmic organelles,
including mitochondria, degrade protein aggregates and
aged proteins [8, 9]. Although the renoprotective eﬀects of
autophagy have been shown in several animal experimental
models such as aging [10] and acute kidney injury [11–
14], the role of autophagy in diabetic nephropathy remains
unknown. Moreover, Sirt1 is one of the positive regulators2 Experimental Diabetes Research
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Figure 1: DR ameliorates urinary albumin excretion (a) and creatinine clearance (Ccr) (b) in Wistar fatty rats (WFRs). Treatment with DR
reduced urinary albumin excretion and improved Ccr in WFRs. Data are means ± SD (n = 9−11, #P<0.01 versus other groups, ##P<0.05
versus other groups).
of autophagy [15]. However, there is little information on
whether DR ameliorates nephropathy in type 2 diabetes,
and if so, whether the eﬀects of DR are associated with
Sirt1 through anti-inﬂammatory function or through the
regulation of autophagy.
Therefore, the aim of this study was to investigate the
potential eﬀects of DR on inﬂammation and the regulation
of autophagy in the diabetic kidney. We demonstrated
that DR attenuated inﬂammation related to the increase in
acetylated-NF-κB and the dysregulation of autophagy as a
result of normalized mitochondrial morphologies through
restoration of Sirt1 expression in the kidneys of WFRs.
2.Research DesignandMethods
2.1. Materials and Antibodies. The anti-Sirt1 antibody was
purchased from Millipore (Billerica, Mass). The anti-
phospho-AMPKα (Thr172) and anti-AMPKα (23A3) anti-
bodies were obtained from Cell Signaling Technology (Bev-
erly, MA). The acetylated-NF-κB (p65, K310) and NF-κB
(p65) antibodies were purchased from Abcam (Cambridge,
MA). The anti-ED-1 antibody was purchased from Serotec
(Oxford, UK). The anti-p62/Sqstm1 antibody was obtained
from Medical & Biological Laboratories (Nagoya, Japan).
The Rat Microalbuminuria ELISA kit (NEPHRAT II) was
purchased from Exocell (Philadelphia, P).
2.2. Animals. Male diabetic Wistar fatty (fa/fa) rats (WFRs),
a model of type 2 diabetes, and age-matched nondiabetic
Wistar lean rats (WLRs) were obtained from Takeda Chem-
ical Industries (Osaka, Japan) [16]. At 6 weeks of age, rats
were divided into four groups: WLRs, WFRs and WLRs
treated with DR, and WFRs treated with DR. The DR group
was given a daily 40% restriction of the food consumption
of WLRs or WFRs control rats. Food consumption was
measured twice a week. Body weight and blood glucose
levels were measured every two weeks in all animals. The
blood pressure of conscious rats was measured at steady
state using a programmable tail-cuﬀ sphygmomanometer
(BP98-A; Softron, Tokyo, Japan) once a month. After 24
weeks, individual rats were placed in metabolic cages for 24h
urine collection. The urine samples were stored at −80◦C
until analysis. Rats were anesthetized by an intraperitoneal
injectionofsodiumpentobarbital,andtherightkidneyswere
removed and stored at −80◦C for the experiments described
below. After the collection of blood samples from the left
cardiac ventricle, the left kidney was perfused with ice-cold
phosphate-buﬀered saline (PBS) and 10% neutral-buﬀered
formalin and removed. The Research Center for Animal
Life Science of Kanazawa Medical University approved all
experiments.
2.3. Blood and Urinary Analysis. Glycated-Hb levels were
measured using a DCA 2000 analyzer (Siemens Medical
Solutions Diagnostics, Tokyo, Japan). Triglycerides (TG) and
total cholesterol (T-CHO) were measured using a Pure-
Auto S TG-N kit (Sekisui Medical, Tokyo, Japan) and an L-
type cholesterol H-test kit (Wako Pure Chemical Industries,
Osaka, Japan), respectively. Serum creatinine was measured
using a Cica liquid-S CRE kit (Kanto Chemical Co., Inc,
Tokyo, Japan), and urinary creatinine concentration was
measured with a BioMajesty JCA-BM12 (Hitachi, Tokyo,
Japan). Urinary albumin excretion (UAE) was measured
using an enzyme-linked immunosorbent assay (ELISA) kit,Experimental Diabetes Research 3
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Figure 2: DR ameliorates mesangial expansion and renal ﬁbrosis in WFRs. ((a)-(A) through (D)) Representative photomicrographs of PAS-
stained kidney sections from four groups of rats. Data are the results of independent experiments in each group with six rats per group.
Original magniﬁcation, ×400. (b) Quantitative assessment of the mesangial matrix area in the four groups of rats. Data are means ± SD.
(n = 6, #P<0.01 versus other groups). Treatment with DR reduced glomerular and interstitial ﬁbrosis in WFRs. ((a)-(E) through (H), (I)
through (L)) Representative photomicrographs of Masson-Trichrome staining in the four groups of rats. Data are the results of independent
experiments in each group with six rats per group. Original magniﬁcation, ×400 for glomerular ﬁbrosis and ×100 for interstitial ﬁbrosis. (c)
and (d) Quantitative assessment of ﬁbrosis in the four groups of rats. Data are means ± SD (n = 6, #P<0.01 versus other groups).4 Experimental Diabetes Research
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Figure 3: TGF-β, ﬁbronectin, and collagen IV mRNA expression levels in the kidney. The mRNA expression levels of TGF-β (a), ﬁbronectin
(b), and collagen IV (c) were quantiﬁed using real-time PCR and expressed as fold increases from Wistar lean rats (WLRs). Data are means
± SD (n = 9 −11, #P<0.05 versus other groups).
and the results are expressed as the total amount of albumin
excreted in 24h urine collection. Body weight-adjusted
creatinine clearance (Ccr) was calculated with the following
equation: Ccr = urine creatinine (mg/dL) × urine volume
(μL/min)/serum creatinine (mg/dL)/body wt (g) [17].
2.4. Morphological Analysis and Immunohistochemistry.
Paraﬃns e c t i o n s( 3 μm thick) of the ﬁxed and processed
kidneys were stained with periodic acid/Schiﬀ (PAS) reagent
or Masson-Trichrome. To assess the mesangial expansion,
20 glomeruli, that were randomly selected from each rat
were cut at the vascular pole, and the periodic acid/Schiﬀ-
(PAS-) positive material in the mesangial area and glomeru-
lar tuft area was measured using computer-assisted color
image analysis (Micro Analyzer; Japan Poladigital, Tokyo,
Japan) as described previously [18]. For the semiquantitative
evaluation of ﬁbrosis by Masson-Trichrome staining in the
kidney,20randomlyselectedglomerulusortubulointerstitial
areas per rat were graded in a double-blind manner, as
reported previously, with minor modiﬁcations [10].
Immunohistochemical staining of 3μmp a r a ﬃns e c t i o n s
was performed as described previously [18]. In brief, the
sections were deparaﬃnized and rehydrated by incubating
at room temperature in xylene three times for 3min, in
100% ethanol twice for 3min, in 95% ethanol twice for
3min, and once in Tris-buﬀered saline (TBS; 0.1mol/L Tris-
HCl, pH 7.4, 0.15mol/L NaCl) for 5min. The sections
were immersed in 3% H2O2 absolute methanol solution
at room temperature for 15min. After washing with TBS,
sections were incubated overnight at 4◦Cw i t hp r i m a r y
antibodies raised against ED-1 (1:50), followed by amino
acid polymers that are conjugated to multiple molecules of
peroxidase and antimouse IgG and washed with TBS. The
sections were stained with ACE solution for 20min at roomExperimental Diabetes Research 5
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Figure 4: Treatment with DR suppresses the number of ED-1-positive cells in the kidney of WFRs. ((a)-(A) through (H)) Representative
photomicrographs of renal ED-1-positive cells in the four groups of rats. Data are the results of independent experiments in each group
with six mice per group. Original magniﬁcation, ×400 for glomerular ED-1 staining and ×100 for tubule-interstitial ED-1 staining. (b) and
(c) ED-1-positive cells in glomerular and tubulointerstitial lesions. Data are means ± SD (n = 6, #P<0.05 versus other groups, ##P<0.01
versus other groups).
temperature and washed with distilled water, followed by
counterstaining with hematoxyline. For quantitative analysis
of ED-1 staining, ED-1-labeled cells in the 20 randomly
selected glomeruli and interstitial areas of the renal cortex
were counted per each animal and analyzed individually
as described previously [18, 19]. An investigator who was
blinded to the sample identity performed the image analysis.
2.5. Western Blot Analysis. The renal cortex sample was
homogenized in ice-cold RIPA buﬀer. Samples of protein
solutions from the kidney were used for Western blotting.
These samples were separated on 15% SDS-PAGE gels and
transferred to a polyvinylidene diﬂuoride ﬁlter (Immobilon;
Millipore, Bedford, MA). After blocking with 5% milk, the
ﬁlterwasincubated overnightwithananti-acetylated-NF-κB
(p65) (1:1000), NF-κB (1:1000), p62/Sqstm1 (1:1000), or
Sirt1antibody(1:1000)at4◦C.Theﬁlterwasthenincubated
with the appropriate HRP-conjugated secondary antibod-
ies (Amersham, Buckinghamshire, UK), and the bands
were detected by enhanced chemiluminescence (Amersham,
Buckinghamshire, UK).
2.6. Quantitative RT-PCR. The isolation of total RNA
from the renal cortex and the determination of cDNA
synthesis by reverse transcription and quantitative real-
time PCR were performed as described previously
[14]. The PCR primer sets are listed below. TGF-β:
sense (5 -3 )TGCGCCTGCAGAGATTCAAG, antisense
(5 -3 ) AGGTAACGCCAGGAATTGTTGCTA, ﬁbronectin:
sense (5 -3 ) GCACATGTCTCGGGAATGGA, antisense6 Experimental Diabetes Research
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Figure 5: MCP-1, ICAM-1, and VCAM-1 mRNA expression levels in the kidney. The mRNA expression levels of MCP-1 (a), ICAM-1 (b),
andVCAM-1(c)werequantiﬁedusingreal-timePCRandexpressedasfoldincreasesfromWistarfattyrats.Dataaremeans ±SD(n = 9−11,
#P<0.05 versus other groups).
(5 -3 ) ACACGTGCAGGAGCAAATGG, collagen IV: sense
(5 -3 ) GTGTCAGCAATTAGGCAGGTCAAG, antisense
(5 -3) CTGGTGTTGGAAACCCTGTGAA, MCP-1: Sense
(5 -3 ) CTATGCAGGTCTCTGTCACGCTTC, antisense
(5 -3 ) CAGCCGACTCATTGGGATCA, ICAM-1: sense
(5 -3 ) ACAAGTGCCGTGCCTTTAGCTC, Anti-sense
(5 -3 ) GATCACGAAGCCCGCAATG, VCAM-1: sense
(5 -3 ) GGA-TGCCGGAGTATACGAGTGTG, antisense
(5 -3 ) CAATGGCGGGTATTACCAAGGA,18S: Sense
(5 -3 ) TTCCGATAACGAACGAGACTCT, Anti-sense
(5 -3 ) TGGCTGAACGCCACTTGTC.
2.7.ElectronMicroscopy. Partoftheharvestedkidneywascut
into small tissues blocks (1mm3) and ﬁxed in 2% glutaralde-
hyde in 0.1M potassium phosphate sodium buﬀer at 4◦Cf o r
examination by electron microscopy. After postﬁxation with
2% osmium tetroxide, tissues were dehydrated in a series of
graded ethanol solutions. Ethanol was then substituted for
propylene oxide, and the samples were embedded in epoxy
resin. Ultrathin sections were double stained with uranyl
acetate and lead citrate. Sections were examined using a
JEM1200EX electron microscope (JEOL, Tokyo) at 80keV.
The mitochondria morphology and autophagosomes in the
proximal tubular cells were observed by electron microscopy
as described previously [10, 14].
2.8. Statistical Analysis. Data are expressed as means ± SD.
The Tukey multiple-comparison test was used to determine
the signiﬁcance of pairwise diﬀerences among three or more
groups. P<0.05 was considered signiﬁcant.Experimental Diabetes Research 7
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Figure 6: Acetylated-NF-κB (p65) and Sirt1 expression in the kidney. (a) Representative immunoblots of Sirt1, acetylated-NF-κB (p65),
and NF-κB in protein extracts from the kidneys of rats of each group. Actin was loaded as an internal control. (b) Quantitative analysis of
acetylated-NF-κB (p65) protein expression. (c) Quantitative analysis of Sirt1 protein expression. Data are means ± SD (n = 6, #P<0.01
versus other groups, ##P<0.05 versus other groups).
3. Results
3.1. Characteristics of Experimental Rats. The characteristics
of the four groups of rats at the end of the experimental
period were shown in Table 1. The whole body and kidney
weights were signiﬁcantly higher in WFRs than in the other
group. The systolic blood pressure (SBP) was not signiﬁ-
cantly changed in any groups. The WFRs exhibited elevated
fasting blood glucose levels and glycated-Hb compared to
WLRs, and DR induced a partial improvement in glycated-
Hb levels by the end of the experimental period. Serum
lipid proﬁles including T-CHO and TG levels were also
signiﬁcantly elevated in WFRs compared to WLRs; the
increases in T-CHO and TG levels were partially rescued by
DR (Table 1).
3.2. Changes in Urinary Albumin Excretion and Creatinine
Clearance (Ccr). To evaluate the eﬀects of DR on renal
dysfunction in WFRs, we measured the urinary albumin
excretion and Ccr. The values for urinary albumin excretion
were higher, and the Ccrs were lower in WFRs than those in
WLRs. Treatment with DR signiﬁcantly reduced the urinary
albuminexcretionandrestoredCcr,whichindicatedthatDR
ameliorated the functional abnormalities of nephropathy in
WFRs (Figures 1(a) and 1(b)).
3.3. Changes in Kidney Morphology. Representative pho-
tomicrographs of mesangial matrix accumulation in the
PAS-stained kidneys of the four groups were shown in
Figure 2(a)—(A)–(D). The results of the quantitative anal-
ysis of mesangial matrix expansion in all groups were
shown in Figure 2(b). Although the ratios of mesangial
matrix/glomerular area were signiﬁcantly larger in WFRs
than that in WLRs, DR signiﬁcantly ameliorated the mesan-
gial expansion in WFRs.
The renal ﬁbrosis determined by Masson-Trichrome
staining (Figure 2(a)—(E) through (H) and (I) through (L))
also revealed a signiﬁcantly higher score for renal glomerular
and tubulointerstitial lesions in WFRs than those in WLRs
(Figures 2(c) and 2(d)). DR reduced the increase in score
for Masson-Trichrome staining in WFRs (Figures 2(c) and
2(d)).
3.4. mRNA Levels of TGF-β1, Fibronectin, and Collagen IV in
the Kidney. We also assessed TGF-β1, ﬁbronectin, and colla-
gen IV mRNA expression levels in the kidney. The mRNA
expression of these ﬁbrosis-related genes was signiﬁcantly
higher in the kidneys of WFRs than that in the kidneys of
WLRs (Figures 3(a)–3(c)). These alterations in WFRs were
improved by DR.8 Experimental Diabetes Research
Table 1: Eﬀects of DR on body weight, kidney weight, blood pressure, blood glucose, glycated-Hb, and lipid proﬁles in the four groups of
rats.
WLRs (n = 1 0 ) W L R s+D R( n = 11) WFRs (n = 1 0 ) W F R s+D R( n = 9)
Body weight (g) 426.3 ± 31.4 264.2 ± 32.7a 671.3 ± 70.3a 489.8 ± 34.8b
Kidney weight (g) 2.8 ± 0.17 1.8 ± 0.06a 3.0 ± 0.35a 2.23 ± 0.91a
Systolic blood pressure (mmHg) 121.9 ± 6.8 113.0 ± 11.0 126.3 ± 15.4 120.3 ± 5.1
Fasting blood glucose (mg/dL) 96.7 ± 8.8 95.7 ± 5.6 111.1 ± 11.9c 115.4 ± 6.1c
Glycated-Hb (%) 3.1 ± 0.25 3.1 ± 0.17 6.1 ± 0.56c 4.9 ± 0.9c,d
Total cholesterol (mg/dL) 132.2 ± 14.6 88.4 ± 6.7a 207 ± 32.3c 164.0 ± 26.5b
Triglyceride (mg/dL) 25.3 ± 4.9 20.5 ± 10.0 179.4 ± 93.3c 77.4 ± 25.5c,d
Data are means ± SD.
Data are means ± SD aP<0.01 versus other groups, bP<0.05 versus other groups, cP<0.01 versus WLRs, WLRs + CR, dP<0.05 versus WFRs.
3.5. Changes in Macrophage Inﬁltration in the Kidney. The
number of ED-1 (a macrophage marker)-positive cells in
the renal glomeruli and interstitial lesions was signiﬁcantly
higher in WFRs than that in WLRs (Figure 4(a)—(A)
through (H)). DR reduced the number of ED-1-positive cells
in the renal glomeruli and interstitial lesions of WFRs.
3.6. mRNA Levels of MCP-1, ICAM-1, and VCAM-1 in the
Kidney. We next determined the mRNA expression levels of
inﬂammation-related genes such as MCP-1, ICAM-1, and
VCAM-1 in the kidney. The mRNA expression of these
genes was signiﬁcantly higher in the kidneys of WFRs than
those of WLRs (Figures 5(a)–5(c)). These changes in WFRs
were almost completely abrogated after DR. The results
in Figures 2–5 indicate that DR reduces glomerular and
interstitial histological abnormalities, including mesangial
expansion, renal ﬁbrosis, and macrophage inﬁltration, in the
kidney of WFRs.
3.7. Changes in the Acetylation of NF-κB and Sirt 1 Protein
Expression in the Kidney. We assessed the changes in acetyla-
tion of NF-κB and Sirt 1 protein expression in the kidney
(Figures 6(a), 6(b),a n d6(c)). The level of acetylated-NF-
κB (p65) was signiﬁcantly increased in the kidney of WFRs
compared to that of WLRs. However, the protein expression
of Sirt1 was decreased in the kidney of WFRs. This increase
in acetylated-NF-κB in the kidney of WFRs was almost
completely reversed, with the level being similar to the
basal levels of WLRs, after treatment with DR, which was
consistent with the restoration of Sirt1 expression.
3.8. Changes in Autophagy in the Kidney. The accumulation
of p62/Sqstm1, which is degraded through an autophagy-
lysosome pathway [8], was signiﬁcantly enhanced in the
kidneys of WFRs (Figures 7(a) and 7(b)). Mitochondrial
morphology was also altered, resulting in marked swelling
and the disintegration of cristae in the renal cortex of WFRs.
Under normal circumstances, damaged mitochondria are
degraded by the intracellular autophagy pathway [8]. In
contrast to the proximal tubular cells of WFRs, DR resulted
in a restoration of abnormal mitochondrial morphology
with numerous autophagosomes in WFRs (Figure 7(c)).
4. Discussion
In this study, we demonstrated the potential beneﬁts of DR
in ameliorating renal injuries of type 2 diabetes. DR exerted
anti-inﬂammatory eﬀects and improved the dysregulation
of autophagy through the restoration of Sirt1 protein
expression in the kidney of WFRs.
Numerous reports have shown that DR extends the
lifespan of yeast, worms, ﬂies, and mammals [3]. Recently,
Colman et al. also reported that DR delayed the onset of age-
associatedpathologies,includingdiabetesandcardiovascular
disease, in rhesus monkeys [4]. Moreover, Fontana et al.
showed that DR in humans improved metabolism and
decreased serum C-reactive protein, TNF-α,a n dc a r o t i d
IMT thickening [20]. These ﬁndings suggest that the various
protective eﬀects of DR against vascular impairment are
exerted through the reduction of vascular inﬂammation,
which is strongly involved in the molecular alterations that
occurinagingorage-relateddiseases[21].Theinﬂammatory
process is one of the pivotal mechanisms for the initiation
and progression of diabetic nephropathy and atherosclerosis
[2]. However, there is little information about whether DR
improves diabetic nephropathy in type 2 diabetes, especially
diabetes-induced inﬂammation in the kidney.
First,weinvestigatedtheeﬀectsofDRonrenalfunctional
and histological abnormalities in a model of type 2 diabetes.
Diabetic WFRs clearly showed increased albuminuria, a
reduction in Ccr, and increased mesangial expansion and
renal ﬁbrosis. Moreover, an increase in macrophage inﬁltra-
tion accompanied by the overexpression of inﬂammation-
related genes, including MCP-1, ICAM-1, and VCAM-1,
was observed in the kidney of WFRs. Treatment with DR
resulted in complete improvement of diabetes-induced renal
injuries, including inﬂammation, and a partial reduction
of glycated-Hb levels by approximately 20% compared to
WFRs. These results indicate that the eﬀects of DR on
diabetic nephropathy may be exerted through other factors
rather than its eﬀects of an improvement of systemic
metabolism such as hyperglycemia and dyslipidemia. What
is the other factor? We here focused on Sirt1 as the other
factor induced by DR because DR is known to signiﬁcantly
increase the levels of Sirt1 protein expression in most tissues,
including the kidney, and the beneﬁcial eﬀects of DR are
linked to Sirt1 activation [5, 6, 22].Experimental Diabetes Research 9
Actin
WLRs
DR
WFRs
− + − +
p62/Sqstm1
(a)
0
1
2
3
4
#
WLRs
DR
WFRs
− + − +
5
6
F
o
l
d
i
n
c
r
e
a
s
e
p62/Sqstm1/Actin
(b)
Autophagosomes
WLRs WFRs WFRs + DR
(c)
Figure 7: p62/Sqptm1 accumulation and electron microscopy in the kidney. (a) Representative immunoblots of p62/sequestosome 1
(Sqptm1) in protein extracts from the kidneys from rats of each group. Actin was loaded as an internal control. Data are means ± SD
(n = 6, #P<0.01 versus other groups). (b) Quantitative analysis of p62/Sqptm1expression. Data are means ± SD (n = 6, #P<0.05 versus
other groups). (c) Representative micrographs of proximal tubular cells from the, four groups of rats. Scale bar = 1μm( n = 3).
Therefore,weaskedwhetherSirt1proteinexpressionwas
altered in the kidney of WFRs. Sirt1 protein expression was
signiﬁcantlydecreasedinthekidneyofWFRsascomparedto
WLRs, and this alteration of Sirt1 expression was restored by
treatment with DR. Sirt1 has anti-inﬂammatory properties
through the deacetylation of NF-κB (p65) [23, 24], which
plays a central role in the regulation of the expression of
inﬂammation-related genes, such as MCP-1, ICAM-1, and
VCAM-1.Severalreportshavealsoshownthatreducedlevels
of Sirt1 lead to the upregulation of acetylated-NF-κB (p65),
resulting in an increase in inﬂammation in the adipose tissue
of high-fat diet-induced obese mice [25] or the monocytes
of patients with chronic obstructive pulmonary disease
(COPD) related to smoking [26]. In the present study, we
showed that acetylated-NF-κB (p65) was clearly increased in
the kidney of WFRs compared to WLRs, and this alteration
of acetylated-NF-κB (p65) in WFRs was lessened by DR.
This result is consistent with the restoration of Sirt1 protein
expression. The p65 subunit of NF-κB selectively interacts
with Sirt1, which promotes the deacetylation of the p65
subunit and leads to the attenuation of the transcriptional
activity of NF-κB and inﬂammation [23]. Therefore, our
results indicate that renal inﬂammation was induced by
increased levels of acetylated-NF-κB (p65) owing to the10 Experimental Diabetes Research
reduced levels of Sirt1 protein expression, and DR exerted
anti-inﬂammatory eﬀects through the restoration of Sirt1
expression in the kidney of WFRs.
Autophagy is a lysosomal degradation pathway in cellss
and plays a crucial role in removing protein aggregates
and damaged or excess organelles, such as mitochondria,
to maintain intracellular homeostasis and maintain the
cell health under various stress conditions [8, 9]. The
renoprotective role of autophagy has been shown in sev-
eral animal experimental models, such as aging [10]a n d
acute kidney injuries [11–14]. In the present study, we
found that mitochondrial morphological damages in the
proximal tubular cells and p62/Sqstm1 accumulation in
diabetic kidneys of WFRs occurred, which suggested that
an impairment of autophagy system induced mitochondrial
damage. Because Sirt1 is one of the positive regulators of
autophagy, the decrease in Sirt1 expression observed in the
diabetic kidney may lead to the dysregulation of autophagy.
In addition, the phosphorylation of AMPK, which positively
regulates Sirt1 activity [27, 28] and autophagy [8], was
also decreased in the diabetic kidney (data not shown).
DR improved the function of autophagy system, which
resulted in normalization of mitochondrial morphological
changes and p62/Sqstm1 accumulation accompanied by the
restoration of Sirt1 expression and AMPK activation in
the kidney of WFRs. We also conﬁrmed the existence of
numerous autophagosomes in the proximal tubular cells of
the kidney in WFRs treated with DR, consistent with the
existence of normal morphological mitochondria. In addi-
tion,whenautophagyisinhibited,p62/Sqstm1accumulation
alterstheNF-κBpathwayandleadstoinﬂammation[29,30].
These data from previous reports suggest that p62/Sqstm1
accumulationassociatedwiththedysregulationofautophagy
is involved in increased inﬂammation. However, the role of
autophagy in the pathogenesis of diabetic nephropathy and
the relationship between inﬂammation and dysregulation of
autophagy are still unclear. Therefore, further study will be
needed to clarify these mechanisms in detail.
5. Conclusions
The current study demonstrated the beneﬁcial eﬀects of
DR on renal injuries, including inﬂammation, in type 2
diabetic nephropathy model. The decrease in Sirt1 protein
expression in the diabetic kidney may lead to inﬂammation
through increased levels of acetylated-NF-κB (p65) and
through the dysregulation of autophagy. DR may ameliorate
the inﬂammation and the dysregulation of autophagy via the
restoration of Sirt1 protein expression in the diabetic kidney.
Therefore, Sirt1 may be a signiﬁcant therapeutic target for
the prevention of nephropathy in type 2 diabetes.
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